Diana R Rohlman

Diana Rohlman serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate the development of medical countermeasures, diagnostic tools, and high-containment laboratory infrastructure for emerging infectious and immunologic threats. She manages complex acquisitions aligned with biomedical research and biosafety requirements, specializing in the procurement of biological products, specialized containment equipment, and related research support services. Her work ensures timely delivery of critical capabilities needed to respond to public health emergencies and sustain advanced research operations under BSL-3 and BSL-4 conditions. Rohlman maintains a focused contractor relationship with Quality Biological, Inc., a leading provider of biological reference materials and research reagents, and Genomic Labs Ltd., a specialist in high-complexity genomic analysis services. These partnerships reflect a preference for established vendors with proven expertise in biosafety-compliant manufacturing and advanced life sciences support. Her contracting approach emphasizes reliability, regulatory compliance, and technical precision, favoring long-term vendor engagement over broad competition. Rohlman’s procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects NIAID’s operational need for specialized, non-duplicable capabilities that are currently available only through a limited pool of highly qualified suppliers with validated biosafety and manufacturing credentials. While small business participation is not formally prioritized, her acquisitions remain compliant with all federal socioeconomic requirements. Her primary procurement focus centers on NAICS 325414 (Biological Product Manufacturing) and 332999 (Miscellaneous Fabricated Metal Product Manufacturing), indicating deep engagement with the production of research-grade biological agents and custom-engineered biocontainment systems. She routinely procures high-integrity biological reagents, pathogen storage systems, and specialized laboratory hardware designed to meet stringent federal biosafety standards.